🔗 Share this article

Given that America undertakes historic changes to its vaccine schedules, one figure appears somewhat surprisingly: Tracy Beth Høeg, a Danish American physician and epidemiologist who rose to prominence by expressing skepticism about Covid shots in the global health crisis and has focused upon alleged deaths following COVID-19 vaccination in her short position at the US Food and Drug Administration (FDA).

Proposed Shifts to Pediatric Immunization Program

Health officials were set to unveil radical revisions to the childhood immunization program recently, aligning the US with the Danish vaccine program, it is understood – a major change that would put the US at odds with a large portion of the international standard with no evidence for benefit. This reveal has been pushed back until the coming year.

In place of Vinay Prasad, Dr. Høeg is set to speak at the event. She was recently named acting director of the FDA’s CDER, the fifth person to head the division this calendar year.

A New Direction at the Agency

The acting appointment may indicate a strengthened alliance between the drug and vaccine centers as Høeg and Dr. Prasad consolidate power at the agency – and it points to a increased emphasis upon rolling back already-approved immunizations at the FDA.

Høeg has often pushed for halting specific childhood immunization guidelines in the US so as to align more in line with the Danish model, a society with universal health coverage and a citizenry about the population of the state of Wisconsin.

In her initial statements, she has persisted in emphasizing on vaccines – traditionally the domain of Prasad, chief of the FDA’s Center for Biologics Evaluation and Research (CBER) – instead of pharmaceutical oversight.

Questions Over Qualifications

The appointee has no apparent track record in drug development, regulation or management, which has been typical for former directors of the CBER. She has served at the FDA as a key advisor to the agency head and the vaccine center since March.

“She appears not to have any of the qualifications” for overseeing the CDER, remarked a neurologist and psychiatrist. “She has not conducted a scientific study. She is not versed in running a major agency. She has no expertise in drug approvals.”

Former commissioners of the center would “grasp regulatory frameworks and the research of medication creation”, said Janet Woodcock. “Objectively, she doesn’t have the type of experience that previous people who headed the center have had.”

This division has an immense range of responsibilities at the FDA, she stated.

“Many people just focuses on the novel medication approvals, but the off-patent medication office authorizes thousands of generic drugs. There is also a biosimilars division, over-the-counter program and more, and all of those need to be managed,” she explained. “The thing you neglect, that’s the thing that I always told people is going to cause problems.”

There is also, a major leadership aspect to the position, which oversees more than 5,000 employees. “It’s a massive administrative position, if you execute it properly,” she said.

Response and Disputed Programs

Regarding concerns about Dr. Høeg's credentials and whether this selection indicates greater collaboration among FDA leaders on vaccines, a spokesperson stated that the “questions are based on incorrect assumptions”.

“Her experience matches the responsibilities of her job,” the spokesperson said, noting the period Høeg spent guiding the agency head on “drug safety and approval science, including predictive safety algorithms and shot safety tracking”.

As acting director, Høeg assumes responsibility for the agency head's recently launched expedited review system, a disputed rapid medication authorization process that allegedly troubled her former heads. “How are these medications being chosen for this fast-track system? Who is making the choices?” Howard said. “There’s a lot of confidentiality happening at the FDA right now.”

In general, he remarked, “the FDA appears to be shifting towards less stringent rules of all drugs, with the exception of vaccines.”

Public Track Record on Immunizations

With vaccines, Høeg has a more established, if problematic, history, critics said. She published a study using unverified crowd-sourced reports to assess the rate of heart inflammation following COVID-19 immunization. She consulted for the state of Florida surgeon general Joseph Ladapo, who was said to have altered data to indicate COVID-19 vaccinations are pose a greater threat than they are.

Part of her “wish list” for the incoming government featured changing regulations for new vaccines and halting “unnecessary” immunizations, she remarked after the election on a audio program. At the agency, Høeg has according to sources floated the idea of excluding adolescent males from obtaining COVID-19 vaccinations.

“She is an all-around ideologue who begins with her conclusions and works backwards to fit the science in a extremely disingenuous, untruthful way,” Howard argued.

Taking Control and a “Revenge Tour”

Høeg aligned with other contrarians, {like|